Michael Murphy

Wall Street wants you to focus on how many times the Fed will cut rates this year even though economic data is coming in stronger than expected. Meanwhile, gold set six straight record highs to close over $2,300 recently for the first time ever, exclaims Michael Murphy, editor at New World Investor.

The EVP of the Kite subsidiary at Gilead Sciences Inc. (GILD) recently presented at the Leerink Partners Global Biopharma Conference. She said the CAR-T industry only has a 15% to 17% share of treatments. A 15% class share for a curative medicine is not acceptable, notes Michael Murphy, editor of New World Investor.

The January Personal Consumption Expenditures (PCE) Index rose 2.4% from last year. The core PCE Index, the Fed’s favorite inflation indicator, rose only 2.8% from last year. That was the lowest annual increase since the 2.2% increase in March 2021. But the stock market did not explode higher until the usual end-of-day ramp, and that was the “dog that didn’t bark,” suggests Michael Murphy, editor of New World Investor.

Apple (AAPL) reported December quarter results above expectations, although analysts focused on Chinese sales below expectations. Meanwhile, Apple announced 600 new spatial computing apps built for the Vision Pro headset. I expect Apple services growth and the Vision Pro to provide plenty of growth, notes Michael Murphy, editor of New World Investor.

Small-cap biotech is not affected by the economy and ignored by the institutions and computerized algo traders. You must Be early, be right, and hold on to turn every $1 into $20 over the next few years. Join this session to learn Michael Murphys three early biotech stock picks. Its his job to be right about the science and getting FDA approval. Its your job to hold on until its time to cash in.